The treatment strategies for SSCDS continue to diversify. A patient-specific approach with systematic documentation of outcomes will continue to inform how these patients are best managed.

Middle ear cholesteatoma is an epithelial lesion that expands into the middle ear, resulting in bone destruction. However, the pathogenesis of this has been…[Read more]

The eATRP-based SI-GOP is easy to operate and low-cost as an amplification strategy. Under optimal conditions, the detection limit for trypsin activity can be down to 0.016 mU mL-1 (~2.68 pM or ~0.064 ng mL-1). As the current signal increases with trypsin activity, this trypsin biosensor is less susceptible to false positives due to the signal-on…[Read more]